| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 23/04/2024 | 13:25 | IH Market News | Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 22/04/2024 | 22:10 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 22/04/2024 | 14:09 | IH Market News | U.S. Index Futures Surge While Wall Street Eyes Rebound on Earnings Focus, Oil Prices Slip | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 02/04/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Second Consecutive Year | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 01/04/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal With insitro for a 6-Year Lease Extension at the Alexandria Center for Advanced Technologies Mega Campus in South San Francisco | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 05/03/2024 | 00:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 04/03/2024 | 22:10 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 1Q24, for an Aggregate of $5.02 per Common Share for the 12 Months Ending March 31, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended March 31, 2 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 04/03/2024 | 13:00 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 01/03/2024 | 20:35 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 28/02/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2024 Operating and Financial Results Conference Call and Webcast on April 23, 2024 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 27/02/2024 | 13:00 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 15/02/2024 | 23:22 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 15/02/2024 | 23:21 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 14/02/2024 | 22:22 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 12/02/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 02/02/2024 | 00:42 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 01/02/2024 | 22:44 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 01/02/2024 | 14:50 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 01/02/2024 | 14:45 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 29/01/2024 | 22:10 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.28 and $8.97, respectively | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 26/01/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 16/01/2024 | 22:20 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 05/01/2024 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 04/01/2024 | 22:57 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 15/12/2023 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Long-Term 165,940 RSF, Full-Building Lease With Novo Nordisk for R&D Center at the Alexandria Center for Life Science - Waltham Mega Campus in Greater Boston | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 14/12/2023 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Long-Term 99,557 RSF Lease With CARGO Therapeutics for Its New Headquarters and R&D Center at the Alexandria Center for Life Science - San Carlos Mega Campus in the San Francisco Bay Area | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 04/12/2023 | 22:10 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Elects Sheila McGrath to Board of Directors | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 04/12/2023 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 4Q23, an Increase of 3 Cents Over 3Q23, and an Aggregate of $4.96 per Common Share for 2023, an Increase of 24 Cents, or 5 Percent, Over 2022 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 30/11/2023 | 14:30 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2023 Operating and Financial Results Conference Call and Webcast on January 30, 2024 | NYSE:ARE | Alexandria Real Estate Equities Inc |
| 28/11/2023 | 14:00 | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego | NYSE:ARE | Alexandria Real Estate Equities Inc |